Osiris Therapeutics (OSIR) Tops Q3 Revs, Loss Views
Tweet
Share
E-mailGet Alerts OSIR Hot Sheet
Price: $18.99 --0%
Financial Fact:
Income from operations: 310K
Today's EPS Names:
UBAB, LOAN, FITB, More
Financial Fact:
Income from operations: 310K
Today's EPS Names:
UBAB, LOAN, FITB, More
Join SI Premium – FREE
Osiris Therapeutics (NASDAQ: OSIR) reported Q3 EPS of ($0.09), $0.05 better than the analyst estimate of ($0.14). Revenue for the quarter came in at $2.15 million versus the consensus estimate of $1.89 million.
For earnings history and earnings-related data on Osiris Therapeutics (OSIR) click here.
For earnings history and earnings-related data on Osiris Therapeutics (OSIR) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- The tech crown switches hands: Apple dethrones Nvidia as $4 trillion king
- Netflix, Intuitive Surgical tumble premarket
- Spirit Blockchain Capital reports AGM results and board changes
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
